Salivary gland dysfunction may occur as a result of common medications, cancer therapy, or Sjogren's syndrome. Affected patients may develop significant oral, dental, and upper gastrointestinal sequelae. This article reviews the basic elements in diagnosis of salivary dysfunction, including initial evaluation and specialized diagnostic procedures. Patient management depends primarily on the severity of salivary dysfunction. More severe permanent forms of dysfunction, such as radiation-induced and Sjogren's syndrome, require long-term care, with preventive measures to maintain the dentition and therapeutic attempts to increase oral fluids.
References
1.
Arthritis Foundation: Arthritis Medical Information Series: Sjogren's Syndrome. Arthritis Foundation, Patient Services Department, Atlanta (1988 ).
Atkinson, J.C., W.D. Travis, S.R. Pillemer, D. Bermudez, A. Wolff, and P.C. Fox: Major Salivary Gland Function in Primary Sjogren's Syndrome and Its Relationship to Clinical Features. J. Rheum. 17:318-322 (1990).
4.
Baum, B.J.: Salivary Gland Fluid Secretion during Aging. J. Am. Geriatr. Soc. 37:453-458 (1989).
5.
Bowen, W.H., D.A. Young, and S.K. Pearson: The Effects of Sucralose on Coronal and Root-Surface Caries. J. Dent. Res. 69:1485-1487 (1990).
6.
Brown, L.R., J.O. White, I.M. Horton, S. Dreizen, and J.L. Streckfuss: Effects of Continuous Fluoride Gel Use on Plaque Fluoride Retention and Microbial Activity. J. Dent. Res. 62:746-751 (1983).
7.
Creutzig, H.: Sialadenitis Following Iodine-131 Therapy for Thyroid Carcinoma (letter). J. Nucl. Med. 26:817 (1985).
8.
Daniels, T.E.: Salivary Histopathology in Diagnosis of Sjogren's Syndrome. Scand. J. Rheum. (Suppl.)61:36-43 (1986).
9.
Dawes, C.: Physiologic Factors Affecting Salivary Flow Rate, Oral Sugar Clearance, and the Sensation of Dry Mouth in Man. J. Dent. Res.66(Spec Iss):648-653 (1987).
10.
Dreizen, S.: Oral Candidiasis. Am. J. Med. (Oct)30:28-33 (1984).
11.
Epstein, J.B., W.E. Decoteau, and A. Wilkinson: Effect of Sialor in Treatment of Xerostomia in Sjogren's Syndrome. Oral Surg. 56:495-499 (1983).
12.
Epstein, J.B. and M.M. Schubert: Synergistic Effect of Sialogogues in Management of Xerostomia after Radiation Therapy. Oral Surg. Oral Med. Oral Pathol. 64:179-182 (1987).
13.
Fox, P.C.: Systemic Therapy of Salivary Gland Hypofunction. J. Dent. Res.66(Spec Iss):689-692 (1987).
14.
Fox, P.C.: Bacterial Infections of Salivary Glands. Current Opinion Dentistry1:411-414 (1991).
15.
Fox, P.C., J.C. Atkinson, A.A. Macynski, A. Wolff, D.S. Kung, I.H. Valdez, W. Jackson, R.A. Delapenha, J. Shiroky, and B.J. Baum: Pilocarpine Treatment of Salivary Gland Hypofunction and Dry Mouth (Xerostomia). Arch. Intern. Med. 151:1149-1152 (1991 ).
16.
Fox, P.C., K.A. Busch, and B.J. Baum: Subjective Reports of Xerostomia and Objective Measures of Salivary Gland Performance. J. Am. Dent. Assoc. 115:581-584 (1987).
17.
Fox, P.C., P.F. Van Der Ven, B.C. Sonies, J.M. Weiffenbach, and B.J. Baum: Xerostomia: Evaluation of a Symptom with Increasing Significance. J. Am. Dent. Assoc. 110:519-525 (1985).
18.
Fox, R.I., F.V. Howell, R.C. Bone, and P. Michelson: Primary Sjögren Syndrome: Clinical and Immunopathologic Features. Semin. Arthritis Rheum. 14:77-105 (1984).
19.
Geddes, D.A. and S.G. McNee: The Effect of 0.2 percent (48 mM) NaF Rinses Daily on Human Plaque Acidogenicity in situ (Stephan Curve) and Fluoride Content. Arch. Oral Biol. 27:765-769 (1982).
20.
Gorsky, M., S. Silverman, and H. Chinn: Burning Mouth Syndrome: A Review of 98 Cases. J. Oral Med. 42:7-9 (1987).
21.
Greenspan, D. and T.E. Daniels: Effectiveness of Pilocarpine in Postradiation Xerostomia. Cancer59:1123-1125 (1987).
22.
Grushka, M. and B.J. Sessle: Burning Mouth Syndrome. Dent. Clin. N. Am. 35:171-184 (1991).
23.
Helm, J.F.: Role of Saliva in Esophageal Function and Disease. Dysphagia4:76-84 (1989).
24.
Hughes, C.V.; Baum, B.J.; Fox, P.C.; Marmary, Y.; Yeh, C.K.; and Sonies, B.C. (1987): Oral-Pharyngeal Dysphagia: A Common Sequela of Salivary Gland Dysfunction, Dysphagia1:173-177.
25.
Kalfas, S., G. Svensater, D. Birkhed, and S. Edwardsson: Sorbitol Adaptation of Dental Plaque in People with Low and Normal Salivary-Secretion Rates. J. Dent. Res. 69:442-446 (1990).
26.
Kassan, S., T. Thomas, and H. Moutsopolous: Increased Risk of Lymphoma in Sicca Syndrome. Ann. Intern. Med. 89:888 (1978).
27.
Korsten, M.A., A.S. Rosman, S. Fishbein, R.D. Shlein, H.E. Goldberg, and A. Biener: Chronic Xerostomia Increases Esophageal Acid Exposure and Is Associated with Esophageal Injury. Am. J. Med. 90:701-706 (1991).
28.
Lewis, M.A., L.P. Samaranayake, and P.J. Lamey: Diagnosis and Treatment of Oral Candidosis. J. Oral Maxillofac. Surg. 49:996-1002 (1991).
29.
Main, B.E., K.C. Calman, M.M. Ferguson, S.B. Kaye, T.W. MacFarlane, R.J. Mairs, L.P. Samaranayake, J. Willox, and J. Welsh: The Effect of Cytotoxic Therapy on Saliva and Oral Flora. Oral Surg. 58:545-548 (1984).
30.
Mandel, I.D.: Sialochemistry in Diseases and Clinical Situations Affecting Salivary Glands. CRC Crit. Rev. Clin. Lab. Sci. Sep:321-335 (1980).
31.
Markovic, N., D.C. Abelson, and I.D. Mandel: Sorbitol Gum in Xerostomics: The Effects on Dental Plaque pH and Salivary Flow Rates. Gerodontology7:71-75 (1988).
32.
Mellberg, J.R.: Evaluation of Topical Fluoride Preparations. J. Dent. Res.69(Spec Iss):771-779 (1990).
33.
Mira, J.G., W.B. Wescott, E.N. Starcke, and I.L. Shannon: Some Factors Influencing Salivary Function When Treating with Radiotherapy. Int. J. Rad. Oncol. Biol. Phys.7:535-541 (1981).
34.
Mossman, K., A. Shatzman, and J. Chencharick: Long-Term Effects of Radiotherapy on Taste and Salivary Function in Man. Int. J. Rad. Oncol. Biol. Phys. 8:991-997 (1982).
35.
Parrago, J., J.D. Rain, C. Brocheriou, and F. Rocher: Scintigraphy of the Salivary Glands in Sjogren's Syndrome. J. Clin. Pathol. 40:1463-1467 (1987).
36.
Schiødt, M., D. Greenspan, T.E. Daniels, J. Nelson, P.J. Leggott, D.W. Wara, and J.S. Greenspan: Parotid Gland Enlargement and Xerostomia Associated with Labial Sialadenitis in HIV-Infected Patients. J. Autoimmunity2:415-425 (1989).
37.
Schiødt, M., P. Oxholm, and A. Jacobsen: Treatment of Xerostomia in Patients with Primary Sjögren's Syndrome with Sulfarlem. Scand. J. Rheum. (Suppl)61:250-252 (1986).
38.
Schubert, M.M. and K.T. Izutsu: Iatrogenic Causes of Salivary Gland Dysfunction, J. Dent. Res.66(Spec Iss):680-688 (1987).
39.
Schubert, M.M., K.M. Sullivan, T.H. Morton, K.T. Izutsu, D.E. Peterson, N. Flournoy, E.L. Truelove, G.E. Sale, C.D. Buckner, E.R. Storb, and E.D. Thomas: Oral Manifestations of Chronic Graft-vs.-Host Disease. Arch. Intern. Med.144:1591-1595 (1984).
40.
Scully, C.: Sjogren's Syndrome: Clinical and Laboratory Features, Immunopathogenesis and Management. Oral Surg. Oral Med. Oral Pathol. 62:510-523 (1986).
41.
Ship, J.A., P.C. Fox, and B.J. Baum: How Much Saliva is Enough? 'Normal' Function Defined. J. Am. Dent. Assoc. 122:63-69 (1991).
42.
Silverberg, E. and J. Lubera: Cancer Statistics. CA37:2-19 (1987).
43.
Sreebny, L.M. and G. Broich: Xerostomia (Dry Mouth). In: The Salivary System, pp. 179-202. ( L. M. Sreebny, Ed.) CRC Press, Boca Raton (1987).
44.
Sreebny, L.M. and A. Valdini: Xerostomia. A Neglected Symptom. Arch. Intern. Med. 147:1333-1337 (1987).
45.
Ukai, Y., H. Taniguchi, K. Takeshita, T. Ogasawara, and K. Kimura: Enhancement of Salivary Secretion by Chronic Anethole Trithione Treatment. Arch. Int. Pharmacodyn. 294:248-258 (1988).
46.
Valdez, I.H.: Radiation-Induced Salivary Dysfunction: Clinical Course and Significance. Spec. Care Dent. 11:252-255 (1991).
47.
Valdez, I.H., J.C. Atkinson, J.A. Ship, and P.C. Fox: Major Salivary Gland Function in Patients with Radiation-Induced Xerostomia: Flow Rates and Sialochemistry. Int. J. Rad. Oncol. Biol. Phys. 25:41-47 (1993).
48.
Valdez, I.H. and P.C. Fox: Interactions of the Salivary and Gastrointestinal Systems. I. The Role of Saliva in Digestion. Dig. Dis. 9:125-132 (1991).
49.
Westin, T., A. Jansson, C. Zenckert, T. Hallstrom, and S. Edstrom: Mental Depression Is Associated with Malnutrition in Patients with Head and Neck Cancer. Arch. Otolaryngol. Head Neck Surg. 114:1449-1453 (1988).
50.
Wright, W.E., J.M. Haller, S.A. Harlow, and P.A. Pizzo: An Oral Disease Prevention Program for Patients Receiving Radiation and Chemotherapy. J. Am. Dent. Assoc. 110:43-47 (1985).
